POST Online Media Lite Edition



 

Pfizer, BioNTech to supply up to 1.8 bln additional doses of COVID-19 vaccine to EU

Christian Fernsby |
Pfizer and BioNTech announced a new agreement with the European Commission to supply 900 million doses of their COVID-19 vaccine Comirnaty (BNT162b2) to the European Union.

Article continues below



Topics: PFIZER    BIONTECH   

As part of the deal, the EC also has an option to increase the number of doses delivered by up to an additional 900 million.

The latest deal is in addition to the 600 million doses that have already been committed to the EU through 2021. The total number of potential doses delivered to the EC, inclusive of all agreements, would be up to 2.4 billion.

The companies plan to manufacture all doses for the EC in the European Union. The additional 900 million agreed doses will delivered on a monthly schedule beginning December 2021 and continuing into 2023.


What to read next

Canada to receive early delivery of Pfizer BioNTech coronavirus vaccine
Australia, New Zealand receive first vaccine shipments
EU to get 4m more doses of BioNTech/Pfizer vaccine